Frederic J Kaye

ORCID

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 7

Top Venues

Cell death discovery

Oncogene

Nature medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Maria V Guijarro, Akbar Nawab, Peter Dib, Sandra Sczerba Burkett, Xiaoping Luo, Michael Feely, Elham Nasri, Robert P Seifert, Frederic J Kaye, Maria Zajac-Kaye
TYMS promotes genomic instability and tumor progression in Ink4a/Arf null background. Oncogene (2023)
Sajid Khan, Patrick Kellish, Nick Connis, Dinesh Thummuri, Janet Wiegand, Peiyi Zhang, Xuan Zhang, Vivekananda Budamagunta, Nan Hua, Yang Yang, Umasankar De, Lingtao Jin, Weizhou Zhang, Guangrong Zheng, Robert Hromas, Christine Hann, Maria Zajac-Kaye, Frederic J Kaye, Daohong Zhou
Co-targeting BCL-X L and MCL-1 with DT2216 and AZD8055 synergistically inhibit small-cell lung cancer growth without causing on-target toxicities in mice. Cell death discovery 9 (1) (2023)
Sajid Khan, Patrick Kellish, Nick Connis, Dinesh Thummuri, Janet Wiegand, Peiyi Zhang, Xuan Zhang, Vivekananda Budamagunta, Nan Hua, Yang Yang, Umasankar De, Lingtao Jin, Weizhou Zhang, Guangrong Zheng, Robert Hromas, Christine Hann, Maria Zajac-Kaye, Frederic J Kaye, Daohong Zhou
Co-targeting BCL-X L and MCL-1 with DT2216 and AZD8055 synergistically inhibit small-cell lung cancer growth without causing on-target toxicities in mice. Cell death discovery 9 (1) (2023)
Sajid Khan, Patrick Kellish, Nick Connis, Dinesh Thummuri, Janet Wiegand, Peiyi Zhang, Xuan Zhang, Vivekananda Budamagunta, Nan Hua, Yang Yang, Umasankar De, Lingtao Jin, Weizhou Zhang, Guangrong Zheng, Robert Hromas, Christine Hann, Maria Zajac-Kaye, Frederic J Kaye, Daohong Zhou
Co-targeting BCL-X L and MCL-1 with DT2216 and AZD8055 synergistically inhibit small-cell lung cancer growth without causing on-target toxicities in mice. Cell death discovery 9 (1) (2023)
Sajid Khan, Patrick Kellish, Nick Connis, Dinesh Thummuri, Janet Wiegand, Peiyi Zhang, Xuan Zhang, Vivekananda Budamagunta, Nan Hua, Yang Yang, Umasankar De, Lingtao Jin, Weizhou Zhang, Guangrong Zheng, Robert Hromas, Christine Hann, Maria Zajac-Kaye, Frederic J Kaye, Daohong Zhou
Co-targeting BCL-X L and MCL-1 with DT2216 and AZD8055 synergistically inhibit small-cell lung cancer growth without causing on-target toxicities in mice. Cell death discovery 9 (1) (2023)
Sajid Khan, Patrick Kellish, Nick Connis, Dinesh Thummuri, Janet Wiegand, Peiyi Zhang, Xuan Zhang, Vivekananda Budamagunta, Nan Hua, Yang Yang, Umasankar De, Lingtao Jin, Weizhou Zhang, Guangrong Zheng, Robert Hromas, Christine Hann, Maria Zajac-Kaye, Frederic J Kaye, Daohong Zhou
Co-targeting BCL-X L and MCL-1 with DT2216 and AZD8055 synergistically inhibit small-cell lung cancer growth without causing on-target toxicities in mice. Cell death discovery 9 (1) (2023)
Benjamin C Creelan, Chao Wang, Jamie K Teer, Eric M Toloza, Jiqiang Yao, Sungjune Kim, Ana M Landin, John E Mullinax, James J Saller, Andreas N Saltos, David R Noyes, Leighann B Montoya, Wesley Curry, Shari A Pilon-Thomas, Alberto A Chiappori, Tawee Tanvetyanon, Frederic J Kaye, Zachary J Thompson, Sean J Yoder, Bin Fang, John M Koomen, Amod A Sarnaik, Dung-Tsa Chen, José R Conejo-Garcia, Eric B Haura, Scott J Antonia
Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial. Nature medicine 27 (8) (2021)

Frederic J Kaye.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Frederic J Kaye